Several patients in the UAE have started to receive treatment from the new antiviral drug for COVID-19. The UAE is the first country in the world to receive Sotrovimab, developed by global innovative biopharmaceutical company, GlaxoSmithKline (GSK). In a radio interview, Dr Omar Najim, executive office director at Abu Dhabi’s Department of Health, said the …

The post UAE begins administering revolutionary treatment for COVID-19 Sotrovimab to COVID-19 patients appeared first on The Filipino Times.